1. Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility
- Author
-
Robert Louis Hoffman, Jill Hallin, Patrick B. Lappin, Jeffery Fan, Gina M. Yanochko, Murphy Sean T, Ricardo Martinez, Isha Rymer, Zhou Zhu, Dac M. Dinh, Brion W. Murray, Matthew A. Marx, Wenyue Hu, Peiquing Sun, Sergei Timofeevski, Dusko Trajkovic, and Alessandra Blasina
- Subjects
Cell cycle checkpoint ,Pyridines ,Physiology ,lcsh:Medicine ,Apoptosis ,Cell Cycle Proteins ,Mice, SCID ,Piperazines ,Histones ,Mice ,0302 clinical medicine ,Intestine, Small ,Phosphorylation ,RNA, Small Interfering ,lcsh:Science ,0303 health sciences ,Multidisciplinary ,biology ,Cell cycle process ,Protein-Tyrosine Kinases ,3. Good health ,Spindle checkpoint ,030220 oncology & carcinogenesis ,Female ,RNA Interference ,G1 phase ,Research Article ,Cell Survival ,Transplantation, Heterologous ,Mitosis ,Bone Marrow Cells ,Breast Neoplasms ,Protein Serine-Threonine Kinases ,Palbociclib ,03 medical and health sciences ,Cell Line, Tumor ,Animals ,Humans ,Protein Kinase Inhibitors ,Cell Proliferation ,030304 developmental biology ,Cyclin-dependent kinase 4 ,lcsh:R ,Cyclin-Dependent Kinase 4 ,Cyclin-Dependent Kinase 6 ,G1 Phase Cell Cycle Checkpoints ,Rats ,biology.protein ,lcsh:Q ,Cyclin-dependent kinase 6 - Abstract
Cell cycle checkpoint intervention is an effective therapeutic strategy for cancer when applied to patients predisposed to respond and the treatment is well-tolerated. A critical cell cycle process that could be targeted is the mitotic checkpoint (spindle assembly checkpoint) which governs the metaphase-to-anaphase transition and insures proper chromosomal segregation. The mitotic checkpoint kinase Mps1 was selected to explore whether enhancement in genomic instability is a viable therapeutic strategy. The basal-a subset of triple-negative breast cancer was chosen as a model system because it has a higher incidence of chromosomal instability and Mps1 expression is up-regulated. Depletion of Mps1 reduces tumor cell viability relative to normal cells. Highly selective, extremely potent Mps1 kinase inhibitors were created to investigate the roles of Mps1 catalytic activity in tumor cells and normal physiology (PF-7006, PF-3837; K i
- Published
- 2015